<； p >； this description refers to the Crystalline fumarate Salt of (S) - 3,4 - difluoro - [2 - (4 - fluoro - yodofenilamino) phenyl] [3 - hydroxy - 3 - (2 - azetidin piperidin yl) - triazin-1-yl] - methanone.The description also relates to pharmaceutical compositions that include the Crystalline fumarate Salt of (S) - [32 - (4 - difluoro - 2-fluoro-4 - yodofenilamino) phenyl] [3 - hydroxy - 3 - (2 - azetidin piperidin yl) - triazin-1-yl] - methanone.The description also relates to methods for treating cancers comprising administering to a patient in need of Crystalline fumarate Salt of (S) - [32 - (4 - difluoro - 2-fluoro-4 - yodofenilamino) phenyl] [3 - hydroxy - 3 - (2 - azetidin piperidin yl) - triazin-1-yl] - methanone. <； / p >；<；p>；LA PRESENTE DESCRIPCIÓ；N SE REFIERE A LA SAL DE FUMARATO CRISTALINA DE (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-YODOFENILAMINO)FENIL][3- HIDROXI-3-(PIPERIDIN-2-IL)AZETIDIN-1-IL]-METANONA. LA DESCRIPCIÓ；N TAMBIÉ；N SE REFIERE A COMPOSICIONES FARMACÉ；UTICAS QUE COMPRENDEN LA SAL DE FUMARATO CRISTALINA DE (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-YODOFENILAMINO)FENIL][3-HIDROXI-3-(PIPERIDIN-2-IL) AZETIDIN-1-IL]-METANONA. LA DESCRIPCIÓ；N TAMBIÉ；N SE REFIERE A MÉ；TODOS PARA TRATAR CÁ；NCERES QUE COMPRENDEN ADMINISTRARLE A UN PACIENTE QUE LO NECESITA LA SAL DE FUMARATO CRISTALINA DE (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-YODOFENILAMINO)FENIL][3-HIDROXI-3- (PIPERIDIN-2-IL)AZETIDIN-1-IL]-METANONA.<；/p>；
